WHO WE ARE WHAT WE DO OUR AGENCIES JOIN US NEWS CONTACT US Prime Global announces launch of new technical and strategic communications consultancy, Prime Omics Prime Global 9 March, 2021 Prime Global, the international medical communications and market access group, today announced the launch of a new technical and strategic communications consultancy, Prime Omics. Prime Omics will support the decoding of molecular landscapes for precise communications and healthcare access, working alongside the rest of the Prime Global group. Omic-based technologies such as next-generation sequencing and gene expression profiling are rapidly evolving and becoming an integral part of drug discovery, patient diagnosis, patient management, and disease treatment. Prime Omics provides expert guidance on how to decode and characterise data from biological molecules such as DNA, RNA, and proteins, as well as metabolic pathways and microbes, and how to communicate that information to help improve patient outcomes. Valerie Moss, Group Managing Director at Prime Global, says, “Prime Omics has developed organically from scientific expertise within Prime Global. I am proud that our team has a proven track record in interpreting omic data accurately and reliably and translating that information for a range of audiences from bench to bedside, including HCPs, pharma, payers and patients.” Prime Global has experienced exceptional organic growth in recent years, including the 2020 launches of Prime Access, a Market Access consultancy, and IRIS, a high-level strategic consultancy, as well as acquiring a new agency, Cambridge, in May 2020. The company is delighted to rank on several business growth lists such as the Sunday Times Fast Track 100 in 2018, 2019, and 2020, and has been listed in the top ten of the Alantra Fast Pharma 50 in 2019, 2020, and 2021. Find out more about Prime Omics: https://primeglobalpeople.com/prime-omics-part-of-the-prime-global-group/ Industry Awareness, Media, News, Prime Omics Medical Communications, Prime Global Share this post PREVIOUS NEXT Tweets by PrimeGlobalBuzz Related Posts How can we make lung cancer trials more patient-centric? Prime Global 22 November, 2021 In recognition of Lung Cancer Awareness Month, Olivia Kersey, Patient Engagement Strategist, illustrates current opportunities for the pharmaceutical industry to better meet lung cancer patients’ needs across clinical trials and beyond. read more >> Industry Awareness, Media, News, Prime Patient clinical trials, Medical Communications, patient engagement, Prime Global Your guide to patient authorship Prime Global 17 November, 2021 Patient involvement in clinical trial design has evolved to provide opportunity for patients to be involved in medical publications. This evolution has allowed medical publications to gain invaluable patient perspectives on clinical research, by involving patients as authors in the development of plain language summaries and other, more traditional types of research publications1. read more >> Industry Awareness, Media, News, Prime Patient Medical Communications, patient engagement, Prime Global An interview with Kirsty Anderson, Digital Project Lead Prime Global 17 November, 2021 Kirsty Anderson, Digital Project Lead, took the time to discuss all things digital with us! In this interview, she shares insight into her role, the challenges and opportunities of a digital project, and her views on the future of digital. read more >> Industry Awareness, Interview, Media, News careers, Medical Communications, Prime Global The Medical Communications People © Prime Global Medical Communications Ltd. Company Number 3642172 Privacy Policy | Cookie Policy